ContraFect Corporation ContraFect Corporation Nasdaq: CFRX

Navigate ContraFect Corporation

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Lysins
    • Amurins
    • Publications / Posters
    • Video Library
  • Pipeline
    • Overview
    • Exebacase
    • CF-370
    • Gram-negative Lysins
    • Amurins
  • Investors & Media
    • Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Analyst Coverage
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

Press Releases

Investors & Media

  • Home
  • Investors & Media
  • News / Events
  • Press Releases
Investors & Media

Investors & Media

  • Overview
  • News / Events
    • Press Releases
    • Media Coverage
    • Events
    • Email Alerts
  • Presentations
  • Company Information
  • Financial Information
  • Analyst Coverage
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010

ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants

July 21, 2016

ContraFect Presents New CF-301 Data at ASM Microbe 2016

June 21, 2016

ContraFect Announces Presentation of Data at ASM Microbe 2016

June 8, 2016

ContraFect to Present at Jefferies 2016 Healthcare Conference

June 1, 2016

ContraFect Announces First Quarter 2016 Results

May 10, 2016

ContraFect Corporation to Announce First Quarter 2016 Results on May 10, 2016

May 3, 2016

ContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference

March 29, 2016

ContraFect Corporation Announces Organizational Changes

March 22, 2016

ContraFect Announces Fourth Quarter and Full Year 2015 Results

March 15, 2016

ContraFect Corporation to Announce Fourth Quarter and Full Year 2015 Results on March 15, 2016

March 8, 2016

RSS
  • « Previous
  • 1
  • 2
  • 3
  • Next »
© 2023 ContraFect Corporation. All Rights Reserved.
Copyright Privacy Policy Expanded Access Policy Disclaimer Site Map
LinkedIn Twitter